CN Patent

CN105503845A — 去氟卡格列净化合物及其制备方法和应用

Assigned to Beijing Pudekangli Pharmaceutical Technology Development Co Ltd · Expires 2016-04-20 · 10y expired

What this patent protects

本发明涉及一种式(I)所示的去氟卡格列净化合物，去氟卡格列净化合物的制备方法。此外，本发明还提供了去氟卡格列净作为标准对照品的用途。本发明的实施有效的控制了卡格列净产品的质量，从而保证了卡格列净制剂临床使用的安全性和有效性。

USPTO Abstract

本发明涉及一种式(I)所示的去氟卡格列净化合物，去氟卡格列净化合物的制备方法。此外，本发明还提供了去氟卡格列净作为标准对照品的用途。本发明的实施有效的控制了卡格列净产品的质量，从而保证了卡格列净制剂临床使用的安全性和有效性。

Drugs covered by this patent

Patent Metadata

Patent number
CN105503845A
Jurisdiction
CN
Classification
—
Expires
2016-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Pudekangli Pharmaceutical Technology Development Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.